Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Innate Pharma    IPH   FR0010331421

INNATE PHARMA

(IPH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about INNATE PHARMA
01/05SECTOR UPDATE : Health Care Stocks Mixed Premarket Tuesday
MT
01/05ETF PREVIEW : ETFs, Futures Log Gains Ahead of Georgia Senate Election Runoff Re..
MT
01/05SANOFI : Innate Pharma Shares Rise as Sanofi Selects its Anti-Tumor Drug Candida..
MT
01/05Sanofi Selects Innate's First NK Cell Engager as Anti-Tumor Drug Candidate fo..
MT
01/05Innate's First NK Cell Engager Selected by Sanofi as Drug Candidate for Devel..
GL
01/05INNATE PHARMA : first NK cell engager selected by Sanofi as drug candidate for d..
GL
01/04Innate Pharma to Participate in Upcoming Investor Conferences
GL
01/04INNATE PHARMA : to participate in upcoming investor conferences
GL
2020INNATE PHARMA S A : SVB Leerink Downgrades Innate Pharma to Market Perform From ..
MT
2020INNATE PHARMA S A : HC Wainwright Adjusts Innate Pharma's Price Target to $11.50..
MT
2020INNATE PHARMA : to return US and EU Lumoxiti commercialization rights to AstraZe..
AQ
2020MIDDAY REPORT : Wall Street Weaker Midday On Stimulus Woes
MT
2020SECTOR UPDATE : Health Care Stocks Trade Lower Premarket Friday
MT
2020INNATE PHARMA S A : to Give Up License to AstraZeneca's Leukemia Drug Due to Low..
MT
2020Innate Pharma To Return Immunotoxin's Commercialization Rights In US, EU To A..
MT
2020Innate Pharma to Return US and EU Lumoxiti Commercialization Rights to AstraZ..
GL
2020INNATE PHARMA :  Innate Pharma to return US and EU Lumoxiti commercialization ri..
GL
2020Innate Pharma to Present Additional Efficacy Data for Monalizumab in Combinat..
GL
2020INNATE PHARMA : to Present Additional Efficacy Data for Monalizumab in Combinati..
AQ
2020INNATE PHARMA :  Innate Pharma to present additional efficacy data for monalizum..
GL
2020INNATE PHARMA : 2021 financial calendar
GL
2020Innate Pharma 2021 Financial Calendar
GL
2020Goldman Sachs Starts Innate Pharma at Neutral With $4.75 Price Target
MT
2020INNATE PHARMA : reports third quarter 2020 financial results and business update
AQ
2020Innate Pharma Secures EU's PRIME Designation for Lacutamab to Treat Sézary Sy..
MT
2020INNATE PHARMA : Revenue for Q3
PU
2020INNATE PHARMA : reports third quarter 2020 financial results and business update
PU
2020INNATE PHARMA : Reports Third Quarter 2020 Financial Results and Business Update
AQ
2020INNATE PHARMA : reports third quarter 2020 financial results and business update
AQ
2020Innate Pharma Reports Third Quarter 2020 Financial Results and Business Updat..
GL
2020INNATE PHARMA : reports third quarter 2020 financial results and business update
GL
2020INNATE PHARMA : receives PRIME designation from the European Medicines Agency fo..
AQ
2020INNATE PHARMA : to participate in upcoming investor conferences
AQ
2020SECTOR UPDATE : Health Care Stocks Gain Pre-Bell Friday
MT
2020Innate Pharma Secures European Regulator's PRIME Designation For Lacutamab
MT
2020INNATE PHARMA : Receives Prime Designation From the European Medicines Agency fo..
AQ
2020INNATE PHARMA : Receives prime designation from the european medicines agency fo..
GL
2020INNATE PHARMA : Receives prime designation from the european medicines agency fo..
AQ
2020Innate Pharma Receives Prime Designation From the European Medicines Agency f..
GL
2020INNATE PHARMA : to Participate in upcoming investor conferences
AQ
2020INNATE PHARMA : to participate in upcoming investor conferences
AQ
2020INNATE PHARMA : to participate in upcoming investor conferences
GL
2020Innate Pharma to Participate in upcoming investor conferences
GL
2020INNATE PHARMA LAUNCHES HOPECONNECTLE : A New Online Resource for Hairy Cell Leuk..
AQ
2020INNATE PHARMA LAUNCHES HOPECONNECTLE : A New Online Resource for Hairy Cell Leuk..
GL
2020INNATE PHARMA : SA - First patient dosed in monalizumab Phase 3 clinical trial t..
AQ
2020INNATE PHARMA : Gets $50 Million Milestone Payment From AstraZeneca
DJ
2020INNATE PHARMA : First patient dosed in monalizumab Phase 3 clinical trial trigge..
AQ
2020ASTRAZENECA : First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers..
AQ
2020INNATE PHARMA : First patient dosed in monalizumab Phase 3 clinical trial trigge..
GL
2020First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers $50M Payme..
GL
2020INNATE PHARMA : Interim financial report
PU
2020INNATE PHARMA : reports first half 2020 financial results and business update
AQ
2020INNATE PHARMA : Reports First Half 2020 Financial Results and Business Update
AQ
2020INNATE PHARMA : reports first half 2020 financial results and business update
GL
2020Innate Pharma Reports First Half 2020 Financial Results and Business Update
GL
2020Upcoming Investor Conferences
GL
2020INNATE PHARMA : half-yearly earnings release
2020INNATE PHARMA : obtains EUR6.8M in public funding for its COVID-19 research and ..
AQ
2020Innate Pharma Obtains €6.8M in Public Funding for Its COVID-19 Research And D..
GL
2020Innate Pharma Announces Publication of EXPLORE COVID-19 Translational Study F..
GL
2020INNATE PHARMA : announces the appointment of Joyson Karakunnel, MD, MSC, FACP as..
GL
2020INNATE PHARMA : U.S. Food and Drug Administration lifts partial clinical hold on..
GL
2020U.S. Food and Drug Administration Lifts Partial Clinical Hold on Lacutamab TE..
GL
2020Outcome Of Annual General Meeting Of May 19, 2020
GL
2020INNATE PHARMA : Written questions to the Annual General Meeting
PU
2020INNATE PHARMA : to Present New Efficacy Data For Monalizumab in Combination With..
GL
2020Innate Pharma to Present New Efficacy Data for Monalizumab in Combination Wit..
GL
2020INNATE PHARMA : Revenue for Q1
PU
2020INNATE PHARMA : First Quarter 2020 Report
GL
2020INNATE PHARMA : AGM convening Notice BALO
PU
2020INNATE PHARMA : Financial resolutions tables
PU
2020INNATE PHARMA : Text of resolutions to the 2020 AGM
PU
2020INNATE PHARMA : Auditor's report PCAOB
PU
2020INNATE PHARMA : Convening brochure to the 2020 AGM
PU
1  2  3  4  5  6  7Next
Upcoming event on INNATE PHARMA